Schuppan, D. & Afdhal, N. H. Liver cirrhosis. Lancet 371, 838–851 (2008).
Dissegna, D. et al. Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis. Eur. J. Gastroenterol. Hepatol. 31, 626–632 (2019).
Scaglione, S. et al. The epidemiology of cirrhosis in the United States: A population-based study. J. Clin. Gastroenterol. 49, 690–696 (2015).
Sepanlou, S. G. et al. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: A systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol. Hepatol. 5, 245–266 (2020).
Lombardi, R. et al. FibroScan identifies patients with non-alcoholic fatty liver disease and cardiovascular damage. Clin. Gastroenterol. Hepatol. 18, 517–519 (2020).
Ginès, P. et al. Liver cirrhosis. Lancet 398, 1359–1376 (2021).
Sharma, B. & John, S. Hepatic Cirrhosis. in StatPearls (StatPearls Publishing, 2021).
Gu, W. et al. Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018). Lancet Reg. Health Europe 12, 100240 (2022).
Mokdad, A. A. et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: A systematic analysis. BMC Med. 12, 145 (2014).
Durand, F. & Valla, D. Assessment of prognosis of cirrhosis. Semin. Liver Dis. 28, 110–122 (2008).
Prohić, D., Mesihović, R., Vanis, N. & Puhalović, A. Prognostic markers in patients with decompensated cirrhosis. Med. Glas (Zenica) 11, 99–104 (2014).
Sharma, A. & Nagalli, S. Chronic Liver Disease. in StatPearls (StatPearls Publishing, 2021).
Björnsson, E. et al. Health-related quality of life in patients with different stages of liver disease induced by hepatitis C. Scand. J. Gastroenterol. 44, 878–887 (2009).
Kok, B. et al. Health-related quality of life: A rapid predictor of hospitalization in patients with cirrhosis. Am. J. Gastroenterol. 115, 575–583 (2020).
Orr, J. G. et al. Health related quality of life in people with advanced chronic liver disease. J. Hepatol. 61, 1158–1165 (2014).
Zhang, X., Xi, W., Liu, L. & Wang, L. Improvement in quality of life and activities of daily living in patients with liver cirrhosis with the use of health education and patient health empowerment. Med. Sci. Monit. 25, 4602–4608 (2019).
Macdonald, S. et al. Quality of life measures predict mortality in patients with cirrhosis and severe ascites. Aliment. Pharmacol. Ther. 49, 321–330 (2019).
Post, M. W. M. Definitions of quality of life: What has happened and how to move on. Top. Spinal Cord. Inj. Rehabil. 20, 167–180 (2014).
Kaplan, R. M. & Ries, A. L. Quality of life: Concept and definition. COPD 4, 263–271 (2007).
Boggatz, T. Quality of life in old age – A concept analysis. Int. J. Older People Nurs. 11, 55–69 (2016).
McDonald, T. & Shaw, D. Benchmarking life quality support interventions in long-term care using the long-term care quality of life scale. Nurs. Health Sci. 21, 239–244 (2019).
Annals-XXI, E. Quality of life of seniors in the context of population ageing in Slovakia. Econ. Ann.-XXI http://ea21journal.world/index.php/ea-v152-27/ (2015).
Petrikovičová, L. et al. Is the size of the city important for the quality of urban life? Comparison of a small and a large city. Sustainability 14, 15589 (2022).
Karimi, M. & Brazier, J. Health, health-related quality of life, and quality of Life: What is the difference?. Pharmacoeconomics 34, 645–649 (2016).
Rutkowska, A. et al. stress levels and mental well-being among Slovak students during e-learning in the COVID-19 pandemic. Healthcare (Basel) 9, 1356 (2021).
Murgaš, F. & Petrovič, F. Quality of life and quality of environment in Czechia in the period of the COVID-19 pandemic. Geogr. Cas. 72, 261–274 (2020).
Rišová, K. & Pouš, R. Urban facilities in the quality of life research: A case study of Banská Bystrica city (Central Slovakia). Geogr. Čas. Geogr. Zhurnal Geogr Rev. 70 (2018).
Skladany, L. et al. Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context. EPMA J. 12, 1–14 (2021).
Skladaný, L. et al. Increased mortality and decreased registrations in cirrhosis registry during COVID-19 era. Hepatology 281A–281A (2020).
Skladany, L. et al. Applicability and prognostic value of frailty assessment tools among hospitalized patients with advanced chronic liver disease. Croat. Med. J. 62, 8–16 (2021).
Russell, R. T., Feurer, I. D., Wisawatapnimit, P. & Pinson, C. W. The validity of EQ-5D US preference weights in liver transplant candidates and recipients. Liver Transpl. 15, 88–95 (2009).
Balestroni, G. & Bertolotti, G. EuroQol-5D (EQ-5D): An instrument for measuring quality of life. Monaldi Arch. Chest Dis. 78, 155–159 (2012).
Ragusa, R. et al. Evaluation of health status in patients with hepatitis c treated with and without interferon. Health Qual. Life Outcomes 16, 17 (2018).
Younossi, Z. M., Guyatt, G., Kiwi, M., Boparai, N. & King, D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 45, 295–300 (1999).
EuroQol Group. EuroQol–a new facility for the measurement of health-related quality of life. Health Policy 16, 199–208 (1990).
Rabin, R. & de Charro, F. EQ-5D: A measure of health status from the EuroQol group. Ann Med 33, 337–343 (2001).
Lloyd, A. & Pickard, A. S. The EQ-5D and the EuroQol group. Value Health 22, 21–22 (2019).
Nagel, M. et al. Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relatives. Health Qual. Life Outcomes 18, 10 (2020).
Parkash, O., Iqbal, R., Jafri, F., Azam, I. & Jafri, W. Frequency of poor quality of life and predictors of health related quality of life in cirrhosis at a tertiary care hospital Pakistan. BMC Res Notes 5, 446 (2012).
Solà, E. et al. Factors related to quality of life in patients with cirrhosis and ascites: Relevance of serum sodium concentration and leg edema. J. Hepatol. 57, 1199–1206 (2012).
Les, I. et al. Quality of life in cirrhosis is related to potentially treatable factors. Eur. J. Gastroenterol. Hepatol. 22, 221–227 (2010).
Gastroenterology, C. et al. Depression and anxiety in cirrhosis patients. PracticeUpdate https://www.practiceupdate.com/content/depression-and-anxiety-in-cirrhosis-patients/128629.
Someshwar, H. et al. Does social distancing during the lock down due to Covid-19 outbreak in mumbai affect quality of life?. Int. J. Clin. Biomed. Res. https://doi.org/10.31878/ijcbr.2020.62.01 (2020).
Hwang, T.-J., Rabheru, K., Peisah, C., Reichman, W. & Ikeda, M. Loneliness and social isolation during the COVID-19 pandemic. Int. Psychogeriatr. https://doi.org/10.1017/S1041610220000988 (2020).
Skevington, S. M. et al. Is culture important to the relationship between quality of life and resilience? Global implications for preparing communities for environmental and health disasters. Front. Psychol. 11, 1492 (2020).
Kyutoku, Y. et al. Cognitive and psychological reactions of the general population three months after the 2011 Tohoku earthquake and tsunami. PLoS ONE 7, e31014 (2012).
Coelho, P. Veronika Decides to Die (HarperCollins, 2000).
Chiu, E. et al. Malnutrition impacts health-related quality of life in cirrhosis: A cross-sectional study. Nutr. Clin. Pract. 35, 119–125 (2020).
Maharshi, S., Sharma, B. C. & Srivastava, S. Malnutrition in cirrhosis increases morbidity and mortality. J. Gastroenterol. Hepatol. 30, 1507–1513 (2015).
Sam, J. & Nguyen, G. C. Protein-calorie malnutrition as a prognostic indicator of mortality among patients hospitalized with cirrhosis and portal hypertension. Liver Int. 29, 1396–1402 (2009).
Ando, Y. et al. Sarcopenia impairs health-related quality of life in cirrhotic patients. Eur. J. Gastroenterol. Hepatol. 31, 1550–1556 (2019).
Ebadi, M., Bhanji, R. A., Mazurak, V. C. & Montano-Loza, A. J. Sarcopenia in cirrhosis: From pathogenesis to interventions. J. Gastroenterol. 54, 845–859 (2019).
Sinclair, M., Gow, P. J., Grossmann, M. & Angus, P. W. Review article: sarcopenia in cirrhosis–aetiology, implications and potential therapeutic interventions. Aliment. Pharmacol. Ther. 43, 765–777 (2016).
Nishikawa, H. et al. Health-related quality of life and frailty in chronic liver diseases. Life (Basel) 10, E76 (2020).
Casales da Silva Vieira, R. et al. Cirrhosis affects maximal oxygen consumption, functional capacity, quality of life in patients with hepatitis C. Physiother. Res. Int. 23, 1727 (2018).